Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field of neurology. Leading the journal is an in-depth review of one of the most important events on the neurology calendar, the 2nd Congress of the European Academy of Neurology (EAN), which took place in Copenhagen, Denmark, from May 28th–31st 2016. The journal then presents a selection of peer-reviewed articles that offer significant contributions to the advancement of understanding in neurological disease and provides a perfect springboard for discussion.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles
7 Mins
13th
March
Does the Gut Microbiome Influence the Efficacy of Psychiatric Drugs?
Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified specific…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

5 Mins
13th
March
Systemic Health Impact of Leaky Barriers in the Oral-Gut-Brain Axis
The human body is a holistic system, interconnected by the circulatory, nervous, lymphatic, endocrine, and immune systems that facilitate…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

5 Mins
13th
March
Infliximab-Induced Multifocal Motor Neuropathy
Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder characterised by progressive, asymmetric muscle weakness…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

8 Mins
16th
January
Long-Term Patient Outcomes: The Role of Sustained Treatment Efficacy in Myasthenia Gravis
There have been great advances in the field of generalised myasthenia gravis (gMG) in recent years, but many patients remain dissatisfied…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.